Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 13;8(29):25698-25709.
doi: 10.1021/acsomega.2c07539. eCollection 2023 Jul 25.

Antiproliferative Activity of New Pyrazole-4-sulfonamide Derivatives: Synthesis and Biological Evaluation

Affiliations

Antiproliferative Activity of New Pyrazole-4-sulfonamide Derivatives: Synthesis and Biological Evaluation

Panasa Mahesh et al. ACS Omega. .

Abstract

Pyrazole and sulfonamide constitute an important class of drugs, with several types of pharmacological agents. Facile synthesis of two new series of 3,5-dimethyl-1H-pyrazole-4-sulfonamide and 1,3,5-trimethyl-1H-pyrazole-4-sulfonamide derivatives was designed and synthesized. These pyrazole-4-sulfonamide derivatives are characterized by Fourier transform infrared (FT-IR), 1H NMR, 13C NMR, and elemental analysis, and their biological evolution data are presented. This paved way for the development of new pyrazole-4-sulfonamide derivatives. These compounds are tested for their in vitro antiproliferative activity against U937 cells by the CellTiter-Glo Luminescent cell viability assay using Mitomycin C. Cytotoxicity detection is based on the measurement of LDH activity, while these compounds did not exhibit cytotoxic activity on these cells. Half maximal inhibitory concentration (IC50) was calculated by Graph Pad Prism software for each dose. Their structure-activity relationships were obtained and discussed.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Pharmaceutical drugs in the market with pyrazole heterocyclic and sulfonamide moieties.
Scheme 1
Scheme 1. Synthesis of 3,5-Dimethyl-1H-pyrazole-4-sulfonyl Chloride and 1,3,5-Trimethy-1H-pyrazole-4-sulfonyl Chloride
Reagents and conditions: (a) 85% hydrazine hydrate, methanol, 25–30 °C, yield 95%; (b) potassium tert-butoxide, CH3I, THF, yield 78%; (c) chlorosulfonic acid, SOCl2, CHCl3, 60 °C, yield 90%.
Scheme 2
Scheme 2. Synthesis of 3,5-Dimethyl-N-phenethyl-1H-pyrazole-4-sulfonamide and 1,3,5-Trimethyl-N-phenethyl-1H-pyrazole-4-sulfonamide
Figure 2
Figure 2
FT-IR spectra of N-(2-(cyclohex-1-en-1-yl)ethyl)-1,3,5-trimethyl-1H-pyrazole-4-sulfonamide (MR-S1-2) in CDCl3.
Figure 3
Figure 3
1H NMR spectra of N-(2-(cyclohex-1-en-1-yl)ethyl)-1,3,5-trimethyl-1H-pyrazole-4-sulfonamide (MR-S1-2) in CDCl3.
Figure 4
Figure 4
13C NMR spectra of N-(2-(cyclohex-1-en-1-yl)ethyl)-1,3,5-trimethyl-1H-pyrazole-4-sulfonamide (MR-S1-2) in CDCl3.
Figure 5
Figure 5
HRMS spectra of N-(2-(cyclohex-1-en-1-yl)ethyl)-1,3,5-trimethyl-1H-pyrazole-4-sulfonamide (MR-S1-2).

References

    1. Faisal M.; Saeed A.; Hussain S.; Parsadar D.; Larik F. A. Recent developments in synthetic chemistry and biological activities of pyrazole derivatives. J. Chem. Sci. 2019, 131, 70.10.1007/s12039-019-1646-1. - DOI
    1. Ansari A.; Ali A.; Asif M.; Shamsuzzaman Review: biologically active pyrazole derivatives. New J. Chem. 2017, 41, 16–41. 10.1039/C6NJ03181A. - DOI
    1. Jahangir Alam M. D.; Alam O.; Alam P.; Javed Naim M. A review on pyrazole chemical entity and biological activity. Int. J. Pharma Sci. Res. 2015, 6, 1433–1442.
    1. Eftekhari-Sis B.; Zirak M.; Akbari A. Arylglyoxals in synthesis of heterocyclic compounds. Chem. Rev. 2013, 113, 2958–3043. 10.1021/cr300176g. - DOI - PubMed
    1. Ju Y.; Varma R. S. Aqueous N-Heterocyclization of Primary Amines and Hydrazines with Dihalides: Microwave-Assisted Syntheses of N-Azacycloalkanes, Isoindole, Pyrazole, Pyrazolidine, and Phthalazine Derivatives. J. Org. Chem. 2006, 71, 135–141. 10.1021/jo051878h. - DOI - PubMed